| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
Herbert Irving Comprehensive Cancer Center, Columbia University, College of Physicians and Surgeons, New York, New York 10032-2704
The antitumor effects of the green tea compound epigallocatechin-3-gallate (EGCG) have not been studied in detail previously in head and neck squamous cell carcinoma (HNSCC) cells. Overexpression of the epidermal growth factor receptor (EGFR) occurs frequently in HNSCC, which is an adverse prognostic factor. Therefore, we examined in detail the molecular effects of EGCG on two human HNSCC cell lines, YCU-N861 and YCU-H891, focusing on the EGFR signaling pathway. The 70% lethal dose (IC70) of EGCG for both cell lines was 10 µg/ml. Treatment with EGCG increased the proportion of cells in the G1 phase of the cell cycle and induced apoptosis. In cells treated with EGCG, there was a decrease in the cyclin D1 protein, an increase in the p21Cip1 and p27Kip1 proteins, and a reduction in the hyperphosphorylated form of pRB, changes that may account for the arrest in G1. EGCG also caused a decrease in the Bcl-2 and Bcl-XL proteins, an increase in the Bax protein, and activation of caspase 9, suggesting that EGCG induces apoptosis via a mitochondrial pathway. Treatment with EGCG inhibited phosphorylation of the EGFR, signal transducer and activator of transcription3 (Stat3), and extracellular regulated kinase (ERK) proteins and also inhibited basal and transforming growth factor-
-stimulated c-fos and cyclin D1 promoter activity. EGCG at 0.1 µg/ml (a concentration found in serum after oral administration) markedly enhanced the growth-inhibitory effects of 5-fluorouracil. Taken together, these findings provide insights into molecular mechanisms of growth inhibition by EGCG and suggest that this naturally occurring compound may be useful, when used alone or in combination with other agents, in the chemoprevention and/or treatment of HNSCC.
This article has been cited by other articles:
|
|
 |
|
  S. Adachi, T. Nagao, S. To, A. K. Joe, M. Shimizu, R. Matsushima-Nishiwaki, O. Kozawa, H. Moriwaki, F. R. Maxfield, and I.B. Weinstein (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells Carcinogenesis, October 1, 2008; 29(10): 1986 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Abrams Review: Chemoprevention of esophageal adenocarcinoma Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 7 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Adachi, T. Nagao, H. I. Ingolfsson, F. R. Maxfield, O. S. Andersen, L. Kopelovich, and I. B. Weinstein The Inhibitory Effect of (-)-Epigallocatechin Gallate on Activation of the Epidermal Growth Factor Receptor Is Associated with Altered Lipid Order in HT29 Colon Cancer Cells Cancer Res., July 1, 2007; 67(13): 6493 - 6501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Sartippour, R. Pietras, D. C. Marquez-Garban, H.-W. Chen, D. Heber, S. M. Henning, G. Sartippour, L. Zhang, M. Lu, O. Weinberg, et al. The combination of green tea and tamoxifen is effective against breast cancer Carcinogenesis, December 1, 2006; 27(12): 2424 - 2433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Spinella, L. Rosano, V. Di Castro, S. Decandia, A. Albini, M. R. Nicotra, P. G. Natali, and A. Bagnato Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol. Cancer Ther., June 1, 2006; 5(6): 1483 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhang, X. Tang, Q. Lu, Z. Zhang, J. Rao, and A. D. Le Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1{alpha} protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells Mol. Cancer Ther., May 1, 2006; 5(5): 1227 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lambert, M.-J. Lee, L. Diamond, J. Ju, J. Hong, M. Bose, H. L. Newmark, and C. S. Yang DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES Drug Metab. Dispos., January 1, 2006; 34(1): 8 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Hou, S. Sang, H. You, M.-J. Lee, J. Hong, K.-V. Chin, and C. S. Yang Mechanism of Action of (-)-Epigallocatechin-3-Gallate: Auto-oxidation-Dependent Inactivation of Epidermal Growth Factor Receptor and Direct Effects on Growth Inhibition in Human Esophageal Cancer KYSE 150 Cells Cancer Res., September 1, 2005; 65(17): 8049 - 8056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. E. Lim, M. Mansukhani, and I. B. Weinstein Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells PNAS, April 5, 2005; 102(14): 5156 - 5161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shimizu, A. Deguchi, J. T.E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein (-)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells Clin. Cancer Res., April 1, 2005; 11(7): 2735 - 2746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D Lambert, J. Hong, G.-y. Yang, J. Liao, and C. S Yang Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations Am. J. Clinical Nutrition, January 1, 2005; 81(1): 284S - 291S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shimizu, M. Suzui, A. Deguchi, J. T. E. Lim, D. Xiao, J. H. Hayes, K. P. Papadopoulos, and I. B. Weinstein Synergistic Effects of Acyclic Retinoid and OSI-461 on Growth Inhibition and Gene Expression in Human Hepatoma Cells Clin. Cancer Res., October 1, 2004; 10(19): 6710 - 6721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vittal, Z. E. Selvanayagam, Y. Sun, J. Hong, F. Liu, K.-V. Chin, and C. S. Yang Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray Mol. Cancer Ther., September 1, 2004; 3(9): 1091 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Fassina, R. Vene, M. Morini, S. Minghelli, R. Benelli, D. M. Noonan, and A. Albini Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate Clin. Cancer Res., July 15, 2004; 10(14): 4865 - 4873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mukhtar and M. Pellecchia Correspondence re: M. Leone et al., Cancer Prevention by Tea Polyphenols Is Linked to Their Direct Inhibition of Antiapoptotic Bcl-2-Family Proteins. Cancer Res 2003;63:8118-21. Cancer Res., April 1, 2004; 64(7): 2639 - 2640. [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Sah, S. Balasubramanian, R. L. Eckert, and E. A. Rorke Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling Pathway: EVIDENCE FOR DIRECT INHIBITION OF ERK1/2 AND AKT KINASES J. Biol. Chem., March 26, 2004; 279(13): 12755 - 12762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shimizu, M. Suzui, A. Deguchi, J. T. E. Lim, and I. B. Weinstein Effects of Acyclic Retinoid on Growth, Cell Cycle Control, Epidermal Growth Factor Receptor Signaling, and Gene Expression in Human Squamous Cell Carcinoma Cells Clin. Cancer Res., February 1, 2004; 10(3): 1130 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kaput and R. L. Rodriguez Nutritional genomics: the next frontier in the postgenomic era Physiol Genomics, January 15, 2004; 16(2): 166 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lambert, M.-J. Lee, H. Lu, X. Meng, J. J. J. Hong, D. N. Seril, M. G. Sturgill, and C. S. Yang Epigallocatechin-3-Gallate Is Absorbed but Extensively Glucuronidated Following Oral Administration to Mice,2 J. Nutr., December 1, 2003; 133(12): 4172 - 4177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Lambert and C. S. Yang Mechanisms of Cancer Prevention by Tea Constituents J. Nutr., October 1, 2003; 133(10): 3262S - 3267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Masuda, M. Suzui, J. T. E. Lim, and I. B. Weinstein Epigallocatechin-3-gallate Inhibits Activation of HER-2/neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells Clin. Cancer Res., August 1, 2003; 9(9): 3486 - 3491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chen, G. Shen, V. Hebbar, R. Hu, E. D. Owuor, and A.-N.T. Kong Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells Carcinogenesis, August 1, 2003; 24(8): 1369 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. McCarthy Rethinking Nutritional Support for Persons with Cancer Cachexia Biol Res Nurs, July 1, 2003; 5(1): 3 - 17. [Abstract] [PDF]
|
|
|
|
|
|
J. Hong, H. Lu, X. Meng, J.-H. Ryu, Y. Hara, and C. S. Yang Stability, Cellular Uptake, Biotransformation, and Efflux of Tea Polyphenol (-)-Epigallocatechin-3-Gallate in HT-29 Human Colon Adenocarcinoma Cells Cancer Res., December 15, 2002; 62(24): 7241 - 7246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kazi, D. M. Smith, Q. Zhong, and Q. P. Dou Inhibition of Bcl-XL Phosphorylation by Tea Polyphenols or Epigallocatechin-3-Gallate Is Associated with Prostate Cancer Cell Apoptosis Mol. Pharmacol., October 1, 2002; 62(4): 765 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Levites, T. Amit, M. B. H. Youdim, and S. Mandel Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (-)-Epigallocatechin 3-Gallate Neuroprotective Action J. Biol. Chem., August 16, 2002; 277(34): 30574 - 30580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Masuda, M. Suzui, R. Yasumatu, T. Nakashima, Y. Kuratomi, K. Azuma, K. Tomita, S. Komiyama, and I. B. Weinstein Constitutive Activation of Signal Transducers and Activators of Transcription 3 Correlates with Cyclin D1 Overexpression and May Provide a Novel Prognostic Marker in Head and Neck Squamous Cell Carcinoma Cancer Res., June 1, 2002; 62(12): 3351 - 3355. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
